Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Regen BioPharma Acquires Cancer Vaccine Technology With Initial Focus on Breast Cancer
5/6/2013 11:16:55 AM
More...
|
Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Regen BioPharma Provides Update on Preclinical and Clinical Development
4/5/2013 9:13:44 AM
More...
|
Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Regen BioPharma Initiates Pre-Clinical Study in Support of HemaXellerate™ Cell Therapy
11/19/2012 9:18:59 AM
More...
|
Bio-Matrix Scientific Group Inc. (BMSN.OB) Recruits Senior Scientist for Its Regen BioPharma Subsidiary
6/26/2012 10:27:15 AM
More...
|
Bio-Matrix Scientific Group Inc. (BMSN.OB) Announces David Audley, the Founder of International Cellular Medicine Society, Has Joined the Advisory Board of Its Regen BioPharma Subsidiary
6/18/2012 9:41:05 AM
More...
|
Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Regen BioPharma Subsidiary Executes Option Agreement to License Stem Cell Intellectual Property
6/7/2012 9:09:33 AM
More...
|
Bio-Matrix Scientific Group Inc. (BMSN.OB) Hires President for Its Regen BioPharma Subsidiary
5/8/2012 8:32:11 AM
More...
|
Bio-Matrix Scientific Group Inc. (BMSN.OB) "First in Class" Approach to Stem Cell Medicine
5/3/2012 9:07:55 AM
More...
|
Bio-Matrix Scientific Group Inc. (BMSN.OB) Announces Newly Formed Stem Cell Subsidiary -- Regen BioPharma Inc., Secures $20,000,000 in Institutional Funding
4/30/2012 8:47:51 AM
More...
|
Bio-Matrix Scientific Group Inc. (BMSN.OB) in Discussions on Possible Stem Cell Repository Ventures
10/4/2010 11:36:10 AM
More...
|
|